MedDataX Logo

Westlake Sailing Cohort

NCT ID: NCT04611945

Last Updated: 2022-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-10

Study Completion Date

2022-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Little is known about the dynamic change of human microbiome in different body sites including skin, mouth and gut during sailing. The present study aims to reveal the change of human microbiome in response to the sailing environment in a 1-month period, and its implication for human health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antibiotic Exposure on Gut Microbiota and Motility Establishment in Newborns

NCT06850896

NEC - Necrotizing Enterocolitis
ACTIVE_NOT_RECRUITING

Implications of the Human Microbiota for Health and Disease

NCT04203303

Human Microbiota
RECRUITING

Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)

NCT06095076

Dysbiosis Catheter-Related Infections
UNKNOWN

Integrated Genetic and Functional Analysis of the Female Microbiome in a Flemish Cohort

NCT04319536

Vaginal Microbiome Skin Microbiome Saliva Microbiome
UNKNOWN

Gut Microbiota Pilot Study

NCT03892590

Microbiota Metabolism
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will recruit a number of participants who are going to sail for mariana trench from Shenzhen, China. Characteristics of the participants will be described by a series of index of stool, urine, skin microbiota and tongue coating. All the biospecimen will be collected before and during the voyage. Stool at the 2nd, the 4th and the 12th week after the voyage and blood sample at the baseline will also be collected. Participants' mood states, health-related quality of life, fatigue score and sleep quality will be investigated with questionnaires throughout the 1-month period. Participants are asked to record diseases and symptoms, if any, when sailing. All the data will be used to analyse how microbiota change and be involved in human health during a voyage.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microbiome Glucose Metabolism Mood Environment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willingness and capability to complete the study protocol

Exclusion Criteria

* Inability or unwillingness to approved to provide informed consent.
* Women who are pregnant or lactating.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Westlake University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ju-Sheng Zheng

Role: PRINCIPAL_INVESTIGATOR

Westlake University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Westlake University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20200911ZJS001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 COMPLETED PHASE4
Comparison of Gut Microbiota in Sedentary and Active Women
NCT02901912 COMPLETED
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 UNKNOWN
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
NCT00752219 COMPLETED PHASE2
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221 COMPLETED
Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.
NCT05169255 COMPLETED PHASE3
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 TERMINATED NA
Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis
NCT03526796 UNKNOWN NA
Intestinal Microbiota Composition After Antibiotic Treatment in Early Life
NCT02536560 UNKNOWN
Study of Human Microbiota in Healthy and Pathological Conditions
NCT03460392 UNKNOWN
Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NCT06466707 RECRUITING NA
Baseline Study of Vaginal Microbiota in Healthy Chinses Female Population
NCT04887636 COMPLETED
Gut Microbiota Pilot Study
NCT03897023 UNKNOWN
Intestinal Flora and Metabonomics of Appendicitis
NCT06035029 UNKNOWN
Acute Microbial Switch
NCT05764200 RECRUITING NA
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 UNKNOWN
Amplification and Selection of Antimicrobial Resistance in the Intestine
NCT02058888 COMPLETED
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
NCT04623424 RECRUITING
Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock
NCT06006754 COMPLETED
PRObing The Efficacy of Commercial Stage Storage Buffers and Evaluating Gut Metaproteome Variability Between Individuals
NCT06423508 RECRUITING
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 COMPLETED
Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis
NCT06228937 RECRUITING
Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
NCT00136201 COMPLETED PHASE3
Gut Microbiota in Patients With Peripheral Arterial Disease and Chronic Limb-threatening Ischemia
NCT05757297 NOT_YET_RECRUITING
Study of Antibiotic Utilization Measures and Control of ESBLs in China
NCT00488813 COMPLETED PHASE4